Publications by authors named "C M Rawat"

Unlabelled: Bioinoculants of B90A have been used to decontaminate hexachlorocyclohexane (HCH)-contaminated soils in the past. There is no selective or convenient method available to track the added B90A in HCH-contaminated soils in the presence of several native sphingomonads. Here, we describe a method, BioMarkTrack, for tracking B90A bioinoculant by simple amplification of the B90A specific biomarker genes.

View Article and Find Full Text PDF

The present study used whole-genome data to clarify the taxonomic assignment of two closely related species. Genomic information for 10 type strains was available at the time of conducting this analysis. One group of type strains was found to be conspecific, namely Kämpfer .

View Article and Find Full Text PDF

Prostate cancer (CaP) remains the second leading cause of cancer deaths in western men. CaP mortality results from diverse molecular mechanisms that mediate resistance to the standard of care treatments for metastatic disease. Recently, alternative splicing has been recognized as a hallmark of CaP aggressiveness.

View Article and Find Full Text PDF

There is currently a lot of interest in the construction of point-of-care devices stemming from paper-based origami biosensors. These devices demonstrate how paper's foldability permits the construction of sensitive, selective, user-friendly, intelligent, and maintainable analytical devices for the detection of several ailments. Herein, the first example of the electrochemical aptasensor-based polyvalent dengue viral antigen detection using the origami paper-folding method is presented.

View Article and Find Full Text PDF
Article Synopsis
  • Since its isolation in 1957, rifamycin B has been extensively researched, improving our knowledge of its taxonomy, genetics, and production processes.
  • Key advancements have been made in genetic tools, especially through Heinz Floss's work on cloning vectors and the rifamycin biosynthetic gene cluster, enabling the creation of rifamycin B analogues that could combat multi-drug-resistant tuberculosis.
  • New genomic technologies, like CRISPR, may help enhance the production of these analogues, addressing previous limitations in their yield.
View Article and Find Full Text PDF